High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy

J Chromatogr B Biomed Sci Appl. 2001 May 5;755(1-2):151-6. doi: 10.1016/s0378-4347(01)00059-7.

Abstract

A new high-performance liquid chromatographic method for the determination of efavirenz in human plasma is described. Quantitative recovery following liquid-liquid extraction with diethylether from 200 microl of human plasma was achieved. Subsequently, the assay was performed with 67 mM potassium dihydrogen phosphate-acetonitrile as a mobile phase, a XTerraRP 18 column protected with a Phenomenex C18 column and UV detection at 246 nm. Linear standard curves were obtained for concentrations ranging from 25 to 15,000 ng/ml. The calculated intra- and inter-day coefficients of variation were below 10%.

MeSH terms

  • Alkynes
  • Anti-HIV Agents / blood*
  • Benzoxazines
  • Chromatography, High Pressure Liquid / methods
  • Cyclopropanes
  • Drug Monitoring
  • Drug Therapy, Combination
  • HIV-1*
  • Humans
  • Oxazines / blood*
  • Oxazines / standards
  • Reverse Transcriptase Inhibitors / blood*
  • Sensitivity and Specificity

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz